Effects of Different Doses of Quercetin on Apoptotic Markers and Liver Enzymes in Liver Injury Induced by Interferon Beta-1b (Betaferon) in Male Rats in Comparison with Silymarin
The first disease-modifying drug for the treatment of multiple sclerosis (MS) was interferon beta 1b (IFN).this drug demonstrated efficacy in relapse MS, But There are many difficulties in treating multiple sclerosis, including the well-known side effect of betaferon(hepatotoxicity or liver injury)...
Saved in:
| Main Authors: | Noor Kamel Obead, Inam Sameh Arif, Huda jaber waheed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Pharmacy University of Baghdad
2025-06-01
|
| Series: | Iraqi Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3099 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quercetin Improves the Histopathological Changes of Liver Caused by Interferon Beta 1b-induced Liver Injury
by: Noor kamel Obead, et al.
Published: (2025-05-01) -
Histopathological Changes of Heart, Liver, and Duodenum in Iron Overload: Comparing the Role of Quercetin with Deferoxamine
by: Muntasser A Awad, et al.
Published: (2023-12-01) -
Exploration of the optimal concentration of quercetin liposome nanoparticles for the treatment of liver damage
by: Nana Yin, et al.
Published: (2025-05-01) -
Hepatoprotective Effect of Silymarin Peptide on Carbon Tetrachloride-Induced Acute Liver Injury in Mice
by: Ananda, et al.
Published: (2024-09-01) -
Quercetin mitigates hepatic injury by inhibiting TGF-β/p-Smad3 signaling pathway activation and enhancing AMPK activity in type 2 diabetic rats
by: Hanaa F. B. Gaber, et al.
Published: (2025-04-01)